Evidence map›Paper›PMID 26934726›Full record

ArticlePloS one2016

Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens.

Leticia H Higa, Laura Arnal, Mónica Vermeulen, Ana Paula Perez, Priscila Schilrreff, Cecilia Mundiña-Weilenmann, Osvaldo Yantorno, María Elena Vela, María José Morilla, Eder Lilia Romero

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Leticia H HigaNanomedicine Research Program, Departamento de Ciencia y Tecnologia, Universidad Nacional de Quilmes. Roque Saenz Peña 352, Bernal, Argentina B1876BXD.
Laura ArnalInstituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Universidad Nacional de La Plata-CONICET, Sucursal 4 Casilla de Correo 16, 1900 La Plata, Argentina.
Mónica VermeulenInstituto de Estudios de la Inmunidad Humoral (IDEHU), CONICET-UBA, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires. Junin 956, 4° piso, 1113, Buenos Aires, Argentina.
Ana Paula PerezNanomedicine Research Program, Departamento de Ciencia y Tecnologia, Universidad Nacional de Quilmes. Roque Saenz Peña 352, Bernal, Argentina B1876BXD.
Priscila SchilrreffNanomedicine Research Program, Departamento de Ciencia y Tecnologia, Universidad Nacional de Quilmes. Roque Saenz Peña 352, Bernal, Argentina B1876BXD.
Cecilia Mundiña-WeilenmannCentro de Investigaciones Cardiovasculares, Universidad Nacional de La Plata, La Plata, Argentina.
Osvaldo YantornoFacultad de Ciencias Exactas, Centro de Investigación y Desarrollo de Fermentaciones Industriales (CINDEFI), UNLP. 50 No. 227, 1900 La Plata, Argentina.
María Elena VelaInstituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), Universidad Nacional de La Plata-CONICET, Sucursal 4 Casilla de Correo 16, 1900 La Plata, Argentina.
María José MorillaNanomedicine Research Program, Departamento de Ciencia y Tecnologia, Universidad Nacional de Quilmes. Roque Saenz Peña 352, Bernal, Argentina B1876BXD.
Eder Lilia RomeroNanomedicine Research Program, Departamento de Ciencia y Tecnologia, Universidad Nacional de Quilmes. Roque Saenz Peña 352, Bernal, Argentina B1876BXD.
National University of Quilmes · ARUniversidad Nacional de La Plata · ARCentro de Investigación y Desarrollo en Criotecnología de Alimentos · ARInstitute of Astronomy and Space Physics · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Total antigens from Leishmania braziliensis promastigotes, solubilized with sodium cholate (dsLp), were formulated within ultradeformable nanovesicles (dsLp-ultradeformable archaeosomes, (dsLp-UDA), and dsLp-ultradeformable liposomes (dsLp-UDL)) and topically administered to Balb/c mice. Ultradeformable nanovesicles can penetrate the intact stratum corneum up to the viable epidermis, with no aid of classical permeation enhancers that can damage the barrier function of the skin. Briefly, 100 nm unilamellar dsLp-UDA (soybean phosphatidylcholine: Halorubrum tebenquichense total polar lipids (TPL): sodium cholate, 3:3:1 w:w) of -31.45 mV Z potential, containing 4.84 ± 0.53% w/w protein/lipid dsLp, 235 KPa Young modulus were prepared. In vitro, dsLp-UDA was extensively taken up by J774A1 and bone marrow derive cells, and the only that induced an immediate secretion of IL-6, IL-12p40 and TNF-α, followed by IL-1β, by J774A1 cells. Such extensive uptake is a key feature of UDA ascribed to the highly negatively charged archaeolipids of the TPL, which are recognized by a receptor specialized in uptake and not involved in downstream signaling. Despite dsLp alone was also immunostimulatory on J774A1 cells, applied twice a week on consecutive days along 7 weeks on Balb/c mice, it raised no measurable response unless associated to UDL or UDA. The highest systemic response, IgGa2 mediated, 1 log lower than im dsLp Al2O3, was elicited by dsLp-UDA. Such findings suggest that in vivo, UDL and UDA acted as penetration enhancers for dsLp, but only dsLp-UDA, owed to its pronounced uptake by APC, succeeded as topical adjuvants. The actual TPL composition, fully made of sn2,3 ether linked saturated archaeolipids, gives the UDA bilayer resistance against chemical, physical and enzymatic attacks that destroy ordinary phospholipids bilayers. Together, these properties make UDA a promising platform for topical drug targeted delivery and vaccination, that may be of help for countries with a deficient healthcare system.

Indexed as

Administration, TopicalAnimalsAntigens, ProtozoanCell LineCell SurvivalElastic ModulusHalorubrumHumansLeishmania braziliensisLeishmaniasis, CutaneousLiposomesMembrane LipidsMice, Inbred BALB CProtozoan VaccinesVaccinationAntigens, ProtozoanLiposomesMembrane LipidsProtozoan Vaccines

Identifiers

PMID26934726
PMCPMC4774928
OpenAlexW2288501121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.